hotspot -WSS

hotspot

author：fashion 2025-10-01 02:15:05 - browse：63463

Matts Take Column Illustration — Molly Ferguson for STAT

What do you say to a patient when the FDA rejects “their” experimental drug — one that they believe can alleviate at least some of their suffering?

That question arises in the aftermath of a dramatic moment at the Food and Drug Administration last week. Over the FDA’s protests, a small biotechnology company called BrainStorm Cell Therapeutics had insisted that the agency evaluate its experimental treatment for amyotrophic lateral sclerosis, or ALS, brand named NurOwn. ALS patients made fervent pleas for the medicine, a type of stem cell preparation, based on reports on social media and re-analyses of the data that they thought indicated it might be of some help to those with the fatal disease.

But the FDA methodically dismantled BrainStorm’s application. The medicine couldn’t work the way the company said it would, the agency insisted; the clinical trials didn’t show it was effective; and it was not clear BrainStorm could manufacture the medicine with sufficient quality. Worst of all, more patients died among those who received the drug than those who got placebo. The FDA’s panel of expert advisers voted 17 to 1 that the medicine was not safe and effective, with one person abstaining. The agency doesn’t have to follow the panel’s advice but probably will.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Health care court cases: Humana, Sutter, Novant

WSS

Neutralizing antibodies against HIV shows promise in children

What could happen if Russia blows up the Zaporizhzhia Nuclear Power Plant?

Report captures long Covid’s disabling effects and policy challenges

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

Moderna says combo Covid

Teladoc has a new CEO, but challenges remain the same

focus

hotspot

leisure time

Guidelines to prevent youth baseball injuries need more muscle

Another man arrested in connection with shooting at Kansas nightclub

Affirmative action in medical school literally saved lives

My daughter's legacy lives on through her writing, phage therapy

New air purifier tech could be key to improving indoor air quality

How corporate America is slashing DEI workers amid backlash to diversity programs

ChatGPT in medicine: STAT answers readers' burning questions

How corporate America is slashing DEI workers amid backlash to diversity programs

Medicare details structure of new drug price negotiation program

Trump seeks lengthy delay of classified docs trial, citing upcoming election

focus

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

What to know about a major upcoming Wegovy heart health study

Teladoc has a new CEO, but challenges remain the same

US intelligence assessment says Iran not currently developing nuclear weapons

Titanic submersible: What a 'catastrophic implosion' means and what officials found

Health care court cases: Humana, Sutter, Novant

entertainment

hotspot

focus

leisure time